Clinical trial
Finerenone for Patients With Primary Aldosteronism (FAIRY): A Multicenter, Randomized Clinical Trial
NCT06457074 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Finerenone for Patients With Primary Aldosteronism (FAIRY): A Multicenter, Randomized Clinical Trial
- Lead sponsor
- Chongqing Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 4, 2024
- Completion date
- April 20, 2026
- Enrollment
- 306 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary aldosteronism